• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内聚(聚乳酸-乙醇酸共聚物)/磷酸钙骨水泥复合材料负载重组人骨形态发生蛋白-2的控释

Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.

作者信息

Ruhé P Q, Boerman O C, Russel F G M, Spauwen P H M, Mikos A G, Jansen J A

机构信息

Department of Biomaterials, Radboud University Nijmegen Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

出版信息

J Control Release. 2005 Aug 18;106(1-2):162-71. doi: 10.1016/j.jconrel.2005.04.018.

DOI:10.1016/j.jconrel.2005.04.018
PMID:15972241
Abstract

The release kinetics of recombinant human bone morphogenetic protein-2 (rhBMP-2) loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement (PLGA/Ca-P cement) composites were studied in vivo. RhBMP-2 was radiolabeled with (131)I and entrapped within PLGA microparticles or adsorbed onto the microparticle surface. PLGA microparticles were prepared of high molecular weight (HMW) PLGA (weight average molecular weight [M(w)] 49,100+/-1700) or low molecular weight (LMW) PLGA (M(w) 5,900+/-300) and used for preparation of 30:70 wt.% PLGA/Ca-P cement composite discs. Release of 131I-rhBMP-2 loaded composites was assessed by scintigraphic imaging according to a 2(2) two-level full factorial design in the rat ectopic model during four weeks. In vivo release kinetics varied among formulations. All formulations showed slow release without initial burst, and displayed a linear release from 3 to 28 days. Release of LMW entrapped rhBMP-2 composites (1.7+/-0.3%/day) was significantly faster than release from other formulations (p<0.01). After 28 days, retention within the composites was 65+/-5%, 75+/-4%, 50+/-4% and 70+/-6% of the initial rhBMP-2 for HMW entrapped, HMW adsorbed, LMW entrapped and LMW adsorbed rhBMP-2 composites, respectively. Release from the composite was probably slowed down by an interaction of rhBMP-2 and Ca-P cement after rhBMP-2 release from PLGA microparticles. We conclude that PLGA/Ca-P cement composites can be considered as sustained slow release vehicles and that the release and retention of rhBMP-2 can be modified according to the desired profile to a limited extent.

摘要

在体内研究了负载重组人骨形态发生蛋白-2(rhBMP-2)的聚(dl-乳酸-共-乙醇酸)/磷酸钙骨水泥(PLGA/Ca-P骨水泥)复合材料的释放动力学。rhBMP-2用(131)I进行放射性标记,并包裹于PLGA微粒内或吸附在微粒表面。PLGA微粒由高分子量(HMW)PLGA(重均分子量[M(w)]49,100±1700)或低分子量(LMW)PLGA(M(w)5,900±300)制备,用于制备30:70重量百分比的PLGA/Ca-P骨水泥复合圆盘。根据2(2)两水平全因子设计,在大鼠异位模型中,通过闪烁成像评估负载131I-rhBMP-2复合材料在四周内的释放情况。体内释放动力学因配方而异。所有配方均显示出缓慢释放且无初始突释,并在3至28天内呈线性释放。低分子量包裹rhBMP-2复合材料的释放(1.7±0.3%/天)明显快于其他配方(p<0.01)。28天后,对于高分子量包裹、高分子量吸附、低分子量包裹和低分子量吸附rhBMP-2复合材料,复合材料内的保留量分别为初始rhBMP-2的65±5%、75±4%、50±4%和70±6%。rhBMP-2从PLGA微粒释放后,其与Ca-P骨水泥的相互作用可能减缓了复合材料的释放。我们得出结论,PLGA/Ca-P骨水泥复合材料可被视为持续缓慢释放载体,并且rhBMP-2的释放和保留可在一定程度上根据所需情况进行调整。

相似文献

1
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.体内聚(聚乳酸-乙醇酸共聚物)/磷酸钙骨水泥复合材料负载重组人骨形态发生蛋白-2的控释
J Control Release. 2005 Aug 18;106(1-2):162-71. doi: 10.1016/j.jconrel.2005.04.018.
2
rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.可注射聚(DL-乳酸-乙醇酸共聚物)/磷酸钙骨水泥复合材料中重组人骨形态发生蛋白-2的释放
J Bone Joint Surg Am. 2003;85-A Suppl 3:75-81. doi: 10.2106/00004623-200300003-00013.
3
The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats.不同负载重组人骨形态发生蛋白-2的磷酸钙骨水泥植入物在大鼠体内的动力学和生物学活性
J Biomed Mater Res A. 2008 Dec 1;87(3):780-91. doi: 10.1002/jbm.a.31830.
4
Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement.一种由负载重组人骨形态发生蛋白-2的聚乳酸-羟基乙酸共聚物微球与磷酸钙骨水泥组成的新型骨移植复合材料的制备与性能
J Mater Sci Mater Med. 2008 Mar;19(3):1109-16. doi: 10.1007/s10856-007-3050-5. Epub 2007 Aug 15.
5
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin.经白蛋白预处理的负载重组人骨形态发生蛋白-2的多孔磷酸钙骨水泥的体内释放
J Mater Sci Mater Med. 2006 Oct;17(10):919-27. doi: 10.1007/s10856-006-0181-z.
6
Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites.聚(DL-乳酸-共-乙醇酸)/磷酸钙骨水泥复合材料的生物相容性与降解性能
J Biomed Mater Res A. 2005 Sep 15;74(4):533-44. doi: 10.1002/jbm.a.30341.
7
PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics.用于组织工程的聚乳酸-羟基乙酸共聚物微球/磷酸钙骨水泥复合材料:体外释放和降解特性
J Biomater Sci Polym Ed. 2008;19(9):1171-88. doi: 10.1163/156856208785540136.
8
Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.重组人骨形态发生蛋白-2与聚(d,l丙交酯-共-乙交酯)微球的相互作用
Pharm Dev Technol. 1996 Apr;1(1):11-9. doi: 10.3109/10837459609031413.
9
Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/calcium phosphate cement composites.聚合物分子量对可生物降解聚合物/磷酸钙骨水泥复合材料骨生物活性的影响。
Tissue Eng Part A. 2009 Oct;15(10):3183-91. doi: 10.1089/ten.TEA.2008.0694.
10
Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.基于重组人骨形态发生蛋白-2介导的载体-蛋白偶联的旁分泌信号生长因子靶向递送系统
Bone. 2006 Oct;39(4):825-36. doi: 10.1016/j.bone.2006.04.027. Epub 2006 Jun 16.

引用本文的文献

1
Synergistic Effect of QNZ, an Inhibitor of NF-κB Signaling, and Bone Morphogenetic Protein 2 on Osteogenic Differentiation in Mesenchymal Stem Cells through Fibroblast-Induced Yes-Associated Protein Activation.QNZ(一种 NF-κB 信号通路抑制剂)与骨形态发生蛋白 2 在成纤维细胞诱导的 Yes 相关蛋白激活作用下对间充质干细胞成骨分化的协同作用。
Int J Mol Sci. 2023 Apr 22;24(9):7707. doi: 10.3390/ijms24097707.
2
A Doubly Fmoc-Protected Aspartic Acid Self-Assembles into Hydrogels Suitable for Bone Tissue Engineering.一种双Fmoc保护的天冬氨酸自组装成适用于骨组织工程的水凝胶。
Materials (Basel). 2022 Dec 14;15(24):8928. doi: 10.3390/ma15248928.
3
Electron Beam-Treated Enzymatically Mineralized Gelatin Hydrogels for Bone Tissue Engineering.
用于骨组织工程的电子束处理酶促矿化明胶水凝胶
J Funct Biomater. 2021 Oct 8;12(4):57. doi: 10.3390/jfb12040057.
4
Mineralization of Biomaterials for Bone Tissue Engineering.用于骨组织工程的生物材料矿化
Bioengineering (Basel). 2020 Oct 20;7(4):132. doi: 10.3390/bioengineering7040132.
5
BMP and TGFβ use and release in bone regeneration.骨再生中 BMP 和 TGFβ 的应用和释放。
Turk J Med Sci. 2020 Nov 3;50(SI-2):1707-1722. doi: 10.3906/sag-2003-127.
6
Anisotropic Cryostructured Collagen Scaffolds for Efficient Delivery of RhBMP-2 and Enhanced Bone Regeneration.用于高效递送重组人骨形态发生蛋白-2及增强骨再生的各向异性冷冻结构胶原支架
Materials (Basel). 2019 Sep 24;12(19):3105. doi: 10.3390/ma12193105.
7
The Osteoinductive Effect of Controlled Bone Morphogenic Protein 2 Release Is Location Dependent.控制释放骨形态发生蛋白 2 的成骨诱导作用具有位置依赖性。
Tissue Eng Part A. 2019 Feb;25(3-4):193-202. doi: 10.1089/ten.TEA.2017.0427. Epub 2019 Jan 30.
8
Calcium phosphate cements for bone engineering and their biological properties.用于骨工程的磷酸钙骨水泥及其生物学特性。
Bone Res. 2017 Dec 20;5:17056. doi: 10.1038/boneres.2017.56. eCollection 2017.
9
Bone Regeneration Using Bone Morphogenetic Proteins and Various Biomaterial Carriers.使用骨形态发生蛋白和各种生物材料载体的骨再生
Materials (Basel). 2015 Apr 15;8(4):1778-1816. doi: 10.3390/ma8041778.
10
Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.骨形态发生蛋白的制剂、传递和稳定性:有效骨再生。
Pharm Res. 2017 Jun;34(6):1152-1170. doi: 10.1007/s11095-017-2147-x. Epub 2017 Mar 24.